BridgeBio Oncology Therapeutics, Inc. (BBOT) insider trading.
In Q3 2026, insiders at BridgeBio Oncology Therapeutics, Inc. reported 10 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 5
- Last filed
- 2026-09-14
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Chen Bihua | Director, TenPercentOwner | 4 | 0 | 0 |
| Cobo Marc | Officer · Principal Accounting Officer | 3 | 0 | 0 |
| Beltran Pedro | Director, Officer · President and CEO | 1 | 0 | 0 |
| Ben Yong | Officer · Chief Med & Dev Officer | 1 | 0 | 0 |
| Elmelech Idan | Officer · COO & Principal Financial Ofcr | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-10 | Cobo Marc | A (A) | 9,038 | $0 | 14,344 | Form 4 |
| 2026-09-10 | Cobo Marc | F (D) | 203 | $5.52 | 14,141 | Form 4 |
| 2026-07-01 | Beltran Pedro | F (D) | 1,047 | $7.8 | 44,576 | Form 4 |
| 2026-07-01 | Ben Yong | F (D) | 1,047 | $7.8 | 44,576 | Form 4 |
| 2026-07-01 | Elmelech Idan | F (D) | 343 | $7.8 | 14,495 | Form 4 |
| 2026-07-01 | Cobo Marc | F (D) | 125 | $7.8 | 5,306 | Form 4 |
| 2026-07-01 | Chen Bihua | J (A) | 130,865 | $0 | 6,083,221 | Form 4 |
| 2026-07-01 | Chen Bihua | J (A) | 1,704,862 | $0 | 5,010,332 | Form 4 |
| 2026-07-01 | Chen Bihua | J (A) | 2,692,459 | $0 | 4,879,995 | Form 4 |
| 2026-07-01 | Chen Bihua | J (D) | 4,528,186 | $0 | 0 | Form 4 |
Transaction codes in this quarter
Get BBOT insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1869105&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · BBOT company page · BridgeBio Oncology Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling BridgeBio Oncology Therapeutics, Inc. (BBOT)?
In Q3 2026, insiders at BridgeBio Oncology Therapeutics, Inc. reported 10 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these BridgeBio Oncology Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/bbot.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.